IL17RB and Down syndrome: Structural and biochemical studies have shown a non-enzymatic protective effect of the CSN on SRs such as the DNA damage binding protein-2 (DDB2) and Cockayne syndrome A1 (CSA1) in CRL4-DDB2 and CRL4-CSA1 complexes, respectively [21].